KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $226.1 million.

  • Edwards Lifesciences' Change in Accured Expenses rose 65618.73% to $226.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.3 million, marking a year-over-year increase of 7722.22%. This contributed to the annual value of $89.5 million for FY2024, which is 3869.86% down from last year.
  • According to the latest figures from Q3 2025, Edwards Lifesciences' Change in Accured Expenses is $226.1 million, which was up 65618.73% from $103.7 million recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Change in Accured Expenses peaked at $226.1 million during Q3 2025, and registered a low of -$109.2 million during Q1 2022.
  • In the last 5 years, Edwards Lifesciences' Change in Accured Expenses had a median value of $31.1 million in 2021 and averaged $33.5 million.
  • In the last 5 years, Edwards Lifesciences' Change in Accured Expenses surged by 93406.59% in 2021 and then plummeted by 107419.35% in 2022.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Change in Accured Expenses stood at $31.1 million in 2021, then rose by 10.29% to $34.3 million in 2022, then decreased by 2.62% to $33.4 million in 2023, then tumbled by 109.28% to -$3.1 million in 2024, then surged by 7393.55% to $226.1 million in 2025.
  • Its last three reported values are $226.1 million in Q3 2025, $103.7 million for Q2 2025, and -$103.4 million during Q1 2025.